HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Restoring FTC Monetary Relief Authority: For Commission Members, Not One Size Fits All

Executive Summary

House already passed legislation to amend Sec. 13(b) of FTC regulations and make explicit its authority to obtain injunctive and equitable relief in court, but differences in Democrat and Republican commission appointees' views on the authority was a key topic of discussion during a recent Energy and Commerce hearing.

You may also be interested in...



Wheat, Hi-Tech On Hook For $40M As Appeals Court Rejects Argument Against FTC Authority

“The defendants’ argument rests on a misunderstanding of the basis for the contempt judgment” which were “imposed because the defendants violated the injunction,” says three-judge 11th Circuit panel.

Supreme Court’s AMG Ruling Trimmed FTC’s Toolbox But Didn’t Scalp Its Regulatory Authority

“AMG decision had a dramatic effect on the ability of the FTC to get money in federal court. That said, there are still a lot of ways for the FTC to get money when they bring law enforcement actions,” advertising regulation attorney Daniel Kaufman.

Supplement Direct Seller Pays In Settlement Filed Before US FTC’s Monetary Relief Authority Axed

AdvoCare return money lost in its pyramid scheme requiring distributors to buy thousands of dollars of products to be eligible for cash bonuses, other rewards but compensated distributors for attracting additional recruits, not for sales to customers.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS151604

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel